Cost-effectiveness and budget impact considerations are inherent  in the  the decision-making process for treatment reimbursement. A systematic review of the economic impact of GEP-NETs was carried out using four databases. It has been published recently in the Therapeutic Advances in Endocrinology and Metabolism.

[npfButton size=“small” text=”Read the full article” href=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381439/” background-colour=”#f06124″ text-colour=”#ffffff”]